Related Experiment Videos
[The clinico-anatomical basis for sectioning the vidian nerve]
Vestnik Otorinolaringologii
|July 1, 1992
Summary
Laser vidian nerve destruction via the Nomure approach offers an effective treatment for chronic rhinosinusitis, improving nasal mucosa condition and providing persistent symptom relief.
Area of Science:
- Otorhinolaryngology
- Neurosurgery
- Medical Imaging
Background:
- Chronic polypous rhinosinusitis significantly impacts nasal mucosa health and patient quality of life.
- The vidian nerve plays a role in autonomic innervation influencing nasal secretions and inflammation.
- Current treatments for chronic rhinosinusitis have limitations in achieving persistent symptom control.
Purpose of the Study:
- To evaluate the efficacy and safety of the Nomure transantral subperiosteal approach for vidian nerve sectioning.
- To assess the utility of laser nerve destruction in preventing postoperative complications.
- To determine the effectiveness of vidian nerve sectioning in managing chronic polypous rhinosinusitis.
Main Methods:
- Anatomical study of the pterygopalatine fossa using cadavers, angiography, and X-ray tomography.
- Laser parameters for vidian nerve destruction were optimized in animal models (white rats).
- Seventy surgical interventions were performed utilizing the Nomure approach with laser vidian nerve destruction.
Main Results:
- The Nomure transantral subperiosteal approach demonstrated advantages for accessing the vidian nerve.
- Laser destruction of the vidian nerve was effective in preventing postoperative complications.
- Surgical interventions resulted in persistent symptom response and improved nasal mucosa condition in patients.
Conclusions:
- Vidian nerve sectioning using the Nomure approach with laser ablation is an effective treatment for chronic polypous rhinosinusitis.
- This surgical technique offers a persistent therapeutic response and improves the condition of the nasal mucosa.
- The study supports the Nomure approach as a valuable option for managing refractory chronic rhinosinusitis.